International Cannabis Weekly: 147

• Artemis Growth Partners acquires UK cannabis producer Bridge Farm for US$81 million.
• Lockdown measures are fuelling unprecedented cannabis sales.
• Albania prepares draft law to legalise medical cannabis.
• France’s blanket ban on hemp-derived CBD products contradicts EU laws.
• Hemp and CBG: What will the 2020 consumer look like?

• Czech government announces new licensing system and plans for export.
• The UK’s medical cannabis market shows little growth in early 2020.
• Materia acquires licensed German importer and distributor Cannaktiv.
• XPhyto Therapeutics partners with German brewery for cannabis-infused beverages.
• Terrace Global signs deal with Flowr Corporation to develop Portuguese grow site.

Cannabigerol (CBG) is a rising star within the hemp industry, tipped to follow in the footsteps of CBD as the next non-psychoactive cannabinoid to dominate the low-THC consumer market. We speak to industry leaders, Avicanna and American Hempseed, to understand what is CBG and how it’s set to disrupt the hemp market.

FIND OUT MORE

• Canada’s mental health commission is seeking cannabis-related research proposals.
• Work suspended at Ontario greenhouse after worker tests positive for COVID-19.
• Aurora Cannabis confirms share consolidation will be effective from 11 May.
• Tilray stock drops after reporting ‘worse than expected’ Q1 losses.

• NCIA calls for DEA to stop overseeing the cannabis research application process.
• House legislators add cannabis banking provision in new coronavirus relief bill.
• Michigan sees largest-ever week for recreational cannabis sales.
• Montana hemp farmers establish funding for research and education.
• Maryland medical cannabis sales and patient numbers increase despite COVID-19.
• A California proposal to legalise hemp extracts in food has been delayed until August.

• Australia’s agriculture minister files bill to allow export of medical cannabis and hemp.
• Japan’s Hiro International launches CBD oil made from a compound in orange peel.
• CBD wellness and beauty line MUKOOMI launches in Japan.
• Australia’s THC Global acquires Tetra Health for US$1.93 million.

• Cannabis export rules delayed in Jamaica as lawmakers focus on COVID-19.
• Green Point Research furthers international expansion with Colombian seed licence.
• Argentinian firm prepares to produce the first cannabis-based medicine in Jujuy.

• Israel approves medical cannabis exports, opening the door to international sales.
• Israeli study approved to develop cannabis anti-inflammatories for respiratory issues.
• Africa is vying to become a global leader in cannabis cultivation.

• Pre-clinical study finds CBD may reduce lung inflammation in severe COVID-19 cases.
• Canadian research recommends setting legal age limit for cannabis access at 19.

• MindMed advances Phase 2 LSD microdosing trial for adult ADHD.
• Washington DC activists mail 10,000 decriminalisation petitions to local residents.
• Champignon Brands acquires Californian ketamine infusion treatment centre.
• Two Oregon decriminalisation campaigns work together to boost signature count.
• Activists mark the 1-year anniversary of Denver’s decriminalisation of psilocybin.